initial clinical evaluation showed that 19 of 25 patients with early stages of prostatic cancer and 12 of 14 patients with metastatic prostatic cancer exhibited an elevated enzyme level ( overall 79 % ) , as compared with only six and eight patients , respectively ( overall 36 % ) , by a conventional chemical method .
C0033572
prostatic
C0936223
metastatic prostatic cancer